“There is no justifiable reason for Americans to pay the highest prescription drug prices in the world. High-priced drugs hurt everyone…,” said AARP’s Nancy LeaMond on Trump’s blueprint for bringing down drug costs.
Could the multi-billion dollar ‘pre’ Initial Public Offering (IPO) market be poised to turn to the Blockchain and associated distributed ledger technology (DLT) as an effective and efficient model to raise capital for ventures? Some pundits in the DLT and cryptocurrency space think so.
Molecules produced from the breakdown of food by gut bacteria have been shown for the first time to directly affect cells in the central nervous system.
The prospect of a legal European cannabis market is alluring, and those businesses able to capitalize on the opportunity will become some of the largest cannabis companies in the world. However, U.S. and Canadian operators eyeing the market will discover that entering Europe poses unique challenges.
Judge Daniel Ottolia ruled that the California legislature was hasty in passing the 2015 law, but he put the decision on hold for five days to give the state time to file an emergency appeal.